CONTENTS

Issue 99|October 2020

In association with

timeline

A look back over the history of innovations in antibody-based therapeutics

regulation

What can manufacturers do to ensure that they pass regulatory inspections

Insight

The 'love hormone' oxytocin may have therapeutic potential

technology

AI-enabled risk detection could finesse the pharmaceutical supply chain

Covid-19

The long-term health effects of Covid-19 may put more pressure on the pharma industry

Optometry

Exploring the latest developments in retinitis pigmentosa gene therapies

Fertility

Investment in the fertility sector is growing thanks to novel research projects

innovation

Novel drug developments could improve symptom control for coeliac patients

Comment

Why are many pharma company PV departments failing to automate data capture?

Comment

Harnessing compliance as a lever for doing better business and enhancing market trust

02/24/2024 02:40:09
  • Home | Under the microscope
  • In this issue
  • SHL Medical Company Insight
  • SHL Medical
  • Contents
  • Mimotopes
  • News
  • VEGA Australia
  • Covid-19 executive briefing by GlobalData
  • Wipotec
  • Nasal spray vaccine for Covid-19
  • Datwyler Company Insight
  • Datwyler
  • Covid-19 clinical trials continue to rise in Brazil
  • Biogazelle
  • AstraZeneca’s Phase I / II Covid-19 vaccine trial
  • Swiftpak
  • MTPA resumes screening and enrolment for global Phase III clinical trial of MT-1
  • Biesterfeld
  • The pharma industry briefing
  • From antitoxins to Covid-19 drugs: charting the history of antibody drugs
  • Quality control: pharma manufacturing inspections explained
  • Molnár-Institute Company Insight
  • Molnar-Institute
  • Oxytocin: the therapeutic potential of the ‘love hormone’
  • AI-enabled risk detection in pharma manufacturing
  • Dr. Paul Lohmann
  • Addressing the long-term effects of Covid-19
  • Eyes on the prize: the latest in retinitis pigmentosa gene therapies
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Breaking the taboo: disrupting the fertility sector
  • Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough?
  • Nolato Company Insight
  • Nolato
  • Pharmacovigilance case intake: why the hesitation to automate?
  • Deals in brief powered by GlobalData
  • The key list powered by GlobalData
  • Zenatek
  • Global markets and indices powered by GlobalData
  • Macro-economic indicators (1 of 2) powered by GlobalData
  • Macro-economic indicators (2 of 2) powered by GlobalData
  • Events
  • Next issue
09/23/2020 00:00:00